SignatureFD’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.1K Buy
3,592
+116
+3% +$1.06K ﹤0.01% 2147
2026
Q1
$31.3K Buy
3,476
+288
+9% +$4.54K ﹤0.01% 1987
2025
Q4
$58.1K Buy
3,188
+20
+0.6% +$337 ﹤0.01% 1564
2025
Q3
$46.4K Sell
3,168
-510
-14% -$8.74K ﹤0.01% 1673
2025
Q2
$67K Sell
3,678
-80
-2% -$1.63K ﹤0.01% 1435
2025
Q1
$74.6K Sell
3,758
-10
-0.3% -$173 ﹤0.01% 1365
2024
Q4
$64.6K Sell
3,768
-912
-19% -$17.2K ﹤0.01% 1442
2024
Q3
$93.6K Sell
4,680
-823
-15% -$12.8K ﹤0.01% 1247
2024
Q2
$61.5K Hold
5,503
﹤0.01% 1408
2024
Q1
$36.3K Buy
5,503
+156
+3% +$853 ﹤0.01% 1709
2023
Q4
$24.2K Hold
5,347
﹤0.01% 1831
2023
Q3
$19.1K Hold
5,347
﹤0.01% 1874
2023
Q2
$19.7K Sell
5,347
-41
-0.8% -$152 ﹤0.01% 1898
2023
Q1
$17.8K Buy
5,388
+488
+10% +$1.69K ﹤0.01% 1927
2022
Q4
$19K Hold
4,900
﹤0.01% 1828
2022
Q3
$12K Buy
+4,900
New +$11.8K ﹤0.01% 1974

Other funds holding ADMA

SignatureFD's ADMA Position: Q2 2026 in Review

SignatureFD increased its ADMA Biologics (ADMA) stake by 3.3% in Q2 2026, buying an estimated $1.06K and bringing the position to 3,592 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2147.

SignatureFD first reported a position in ADMA in Q3 2022 and has held it in 16 quarters since. The position peaked at $93.6K in Q3 2024. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • SignatureFD held 3,592 shares of ADMA Biologics worth $30.1K as of Q2 2026.
  • SignatureFD bought 116 ADMA Biologics shares in Q2 2026, an estimated $1.06K.
  • ADMA Biologics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2147 holding.
  • SignatureFD first reported a position in ADMA Biologics in Q3 2022 and has held it in 16 quarters since.
  • SignatureFD's ADMA Biologics position peaked at $93.6K in Q3 2024.
  • 62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.